A carregar...
Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C
OBJECTIVE: Impaired adaptive response to oxidative injuries is a fundamental mechanism central to the pathogenesis of chronic hepatitis C (CHC). Glycogen synthase kinase (GSK) 3β is an indispensable regulator of the oxidative stress response. However, the exact role of GSK3β in CHC is uncertain and...
Na minha lista:
Publicado no: | Gut |
---|---|
Main Authors: | , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4263291/ https://ncbi.nlm.nih.gov/pubmed/24811996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2013-306043 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|